Last reviewed · How we verify
NCT03710174
Evaluation of the Effectiveness of Infrared LED Photobiomodulation in Children With Sleep Bruxism
Phase 2 trial testing Infrared LED photobiomodulation in Bruxism, Sleep in 20 participants. Status unknown.
1 August 2018
Quick facts
| Lead sponsor | University of Nove de Julho |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 August 2017 |
| Primary completion | 1 August 2018 |
| Estimated completion | 10 April 2019 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Infrared LED photobiomodulation
- Occlusal splint
- Placebo LED photobiomodulation
Conditions studied
- Bruxism, Sleep — all drugs for Bruxism, Sleep →
Sponsor
University of Nove de Julho
Who can join
Adults 7 to 10, any sex, with Bruxism, Sleep. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sleep bruxism is a masticatory muscle activity characterized as rhythmic (phasic) or non-rhythmic (tonic). The literature reports the prevalence rates, diverse etiologies and different types of treatment. In children and adolescents, etiological factors, such as breathing pattern and sleep quality, have recently been addressed in studies investigating sleep bruxism. While studies have also reported psychological factors as a causal factor, this aspect requires further research. There are also divergences in opinion regarding the form of treatment. New therapies for adults, such as botulinum toxin, have been investigated, but such techniques are not applicable for individuals in the growth and development phase. Thus, photobiomodulation therapy has piqued the interest of researchers, as this noninvasive method has demonstrated positive results in problems related to muscle tissues. This document describes the protocol for a proposed study to evaluate morphological and psychosocial aspects in children and adolescents with awake bruxism and their responses to photobiomodulation therapy with infrared LED.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of the effectiveness of infrared light-emitting diode photobiomodulation in children with sleep bruxism: Study protocol for randomized clinical trial.
Kobayashi FY, Castelo PM, Gonçalves MLL, Motta LJ, et al · · 2019 · cited 7× · PMID 31567965 · DOI 10.1097/md.0000000000017193
Verify or expand the search:
- PubMed search for NCT03710174
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Nove de Julho trials
Trials by the same sponsor.
- NCT07501143 — Effects of Physical Training in Patients With Advanced Heart Failure · NA · not yet recruiting
- NCT07525310 — Photobiomodulation Effects on Blood Pressure and Vascular Function in Treated Hypertensive Patients · NA · not yet recruiting
- NCT06984796 — Photobiomodulation on Pain Perception During the Insertion of the T 380 Copper Intrauterine Device (IUD) · NA · not yet recruiting
- NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting
- NCT07033039 — Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03710174 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nove de Julho
- Last refreshed: 18 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03710174.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing